<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34819054</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1755-8794</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>24</Day></PubDate></JournalIssue><Title>BMC medical genomics</Title><ISOAbbreviation>BMC Med Genomics</ISOAbbreviation></Journal><ArticleTitle>Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China.</ArticleTitle><Pagination><StartPage>279</StartPage><MedlinePgn>279</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">279</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12920-021-01107-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Hand, foot and mouth disease (HFMD) is caused by a variety of enterovirus serotypes and the etiological spectrum worldwide has changed since a large scale of outbreaks occurred in 1997.</AbstractText><AbstractText Label="METHODS">A large number of clinical specimens of HFMD patients were collected in Xiangyang and genotyping was performed by qRT-PCR, conventional PCR amplification and sequencing. Among the 146 CV-A5 detected cases, the complete genome sequences of representative strains were determined for genotyping and for recombination analysis.</AbstractText><AbstractText Label="RESULTS">It was found that CV-A5 was one of the six major serotypes that caused the epidemic from October 2016 to December 2017. Phylogenetic analyses based on the VP1 sequences showed that these CV-A5 belonged to the genotype D which dominantly circulated in China. Recombination occurred between the CV-A5 and CV-A2 strains with a breakpoint in the 2A region at the nucleotide 3791.</AbstractText><AbstractText Label="CONCLUSIONS">The result may explain the emergence of CV-A5 as one of the major pathogens of HFMD. A multivalent vaccine against HFMD is urgently needed to control the disease and to prevent emerging and spreading of new recombinants.</AbstractText><CopyrightInformation>© 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yuting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhiyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Weiping</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mai</LastName><ForeName>Jianyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Shasha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Zhenni</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Shengli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zejun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Xuhua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Xiangyang Center for Disease Control and Prevention, Hubei, People's Republic of China. Guanxuhua9999@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Yeqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Xiangyang Center for Disease Control and Prevention, Hubei, People's Republic of China. tongyeqing9999@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China. shenshuo1@sinopharm.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Genomics</MedlineTA><NlmUniqueID>101319628</NlmUniqueID><ISSNLinking>1755-8794</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsakievirus A5</Keyword><Keyword MajorTopicYN="N">Hand, foot and mouse disease</Keyword><Keyword MajorTopicYN="N">Recombinantion</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34819054</ArticleId><ArticleId IdType="pmc">PMC8611921</ArticleId><ArticleId IdType="doi">10.1186/s12920-021-01107-6</ArticleId><ArticleId IdType="pii">10.1186/s12920-021-01107-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wei SH, Huang YP, Liu MC, et al. An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect Dis. 2011;11:346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3297538</ArticleId><ArticleId IdType="pubmed">22168544</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T, Iizuka S, Enomoto M, et al. Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis. 2012;18(2):337–339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3310456</ArticleId><ArticleId IdType="pubmed">22304983</ArticleId></ArticleIdList></Reference><Reference><Citation>Di B, Zhang Y, Xie HP, et al. Circulation of coxsackievirus A6 in hand-foot-mouth disease in Guangzhou, 2010–2012. Virol J. 2014;11:157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4169826</ArticleId><ArticleId IdType="pubmed">25178398</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan HY, Wang J, Wang CR, et al. Etiology of multiple non-EV71 and non-CVA16 enteroviruses associated with hand, foot and mouth disease in Jinan, China, 2009-June 2013. PLoS ONE. 2015;10(11):e0142733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4642993</ArticleId><ArticleId IdType="pubmed">26562154</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X, Bian LL, Lu WW, et al. Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated enterovirus A71 vaccine in Jiangsu, China, 2012–2013. J Med Virol. 2015;87(12):2009–2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">26010334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H, Fan H, Lu PX, et al. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden. BMC Infect Dis. 2019;19(1):79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6341624</ArticleId><ArticleId IdType="pubmed">30669973</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu MH, Su LY, Cao LF, et al. Genotypes of the enterovirus causing hand foot and mouth disease in Shanghai, China, 2012–2013. PLoS ONE. 2015;10(9):e0138514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4580587</ArticleId><ArticleId IdType="pubmed">26398767</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaidis M, Mimouli K, Kyriakopoulou Z, et al. Large-scale genomic analysis reveals recurrent patterns of intertypic recombination in human enteroviruses. Virology. 2019;526:72–80.</Citation><ArticleIdList><ArticleId IdType="pubmed">30366300</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu B, Zhong JY, Xia HM, et al. Etiology of hand, foot and mouth disease in Guangzhou in 2008. Chin J Pediatr. 2010;48(2):127–130.</Citation><ArticleIdList><ArticleId IdType="pubmed">20426938</ArticleId></ArticleIdList></Reference><Reference><Citation>Davia JL, Bel PH, Ninet VZ, et al. Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses. Pediatr Dermatol. 2011;28(1):1–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20553401</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZG, Liu XL, Yang TT, et al. Etiology of hand, foot and mouth disease in Qingdao during 2008–2009. Chin J Virol. 2011;27(5):438–441.</Citation><ArticleIdList><ArticleId IdType="pubmed">21998955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding S, Li CR, Wang YH, et al. Epidemiological characteristics of hand-foot-mouth disease and gene features of coxsackievirus A6 and A5 in Xiaogan area from 2014–2016. Occup Health. 2018;34(8):1038–1042.</Citation></Reference><Reference><Citation>Pham NTK, Thongprachum A, Trinh QD, et al. Detection and genetic characterization of enterovirus strains circulating among children with acute gastroenteritis in Japan during 2014–2016. Infect Genet Evol. 2018;61:16–19.</Citation><ArticleIdList><ArticleId IdType="pubmed">29540319</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Huang LM, Lu CY, et al. Atypical hand-foot-mouth disease in children: a hospital-based prospective cohort study. Virol J. 2013;10:209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3717056</ArticleId><ArticleId IdType="pubmed">23800163</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, Ito M, Taniguchi A, et al. Prevalence of coxsackievirus a5, a6, and a10 in patients with herpangina in Aichi prefecture, 2005. Jpn J Infect Dis. 2005;58(6):390–391.</Citation><ArticleIdList><ArticleId IdType="pubmed">16377876</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek KA, Yeo SG, Lee BH, et al. Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009. Virol J. 2011;8:297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3130694</ArticleId><ArticleId IdType="pubmed">21668960</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH, Choi SS, Oh SA, et al. Detection and characterization of enterovirus associated with herpangina and hand, foot and mouth disease in Seoul, Korea. Clin Lab. 2011;57(11–12):959–967.</Citation><ArticleIdList><ArticleId IdType="pubmed">22239028</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KS, Lee BH, Baek KA, et al. Enteroviruses isolated from herpangina and hand-foot-and-mouth disease in Korea children. Virol J. 2012;9:205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3490919</ArticleId><ArticleId IdType="pubmed">22985487</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Mauleekoonphairoj J, Linsuwanon P, et al. Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. PLoS ONE. 2014;9(6):198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4041783</ArticleId><ArticleId IdType="pubmed">24887237</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SJ, Ren Y, Hao XQ, et al. Characteristics of the pathogen for hand-foot-and-mouth disease in Longhua district, Shenzhen in 2018. China Trop Med. 2019;19(3):267–270.</Citation></Reference><Reference><Citation>Meng XD, Tong YQ, Wei ZN, et al. Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China. Sci Rep. 2020;10(1):20909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7708472</ArticleId><ArticleId IdType="pubmed">33262488</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R, Delwart E, Gorbalenya AE, et al. ICTV virus taxonomy profile: Picornaviridae. J Gen Virol. 2017;98(10):2421–2422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Kilpatrick DR, et al. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol. 1999;73(3):1941–1948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104435</ArticleId><ArticleId IdType="pubmed">9971773</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Yan DM, Zhu SL, et al. Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in China: current immunization strategy effectively prevented its sustained transmission. J Infect Dis. 2010;202(12):1780–1788.</Citation><ArticleIdList><ArticleId IdType="pubmed">21050127</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Nix WA, Maher K, et al. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol. 2003;26(3):375–377.</Citation><ArticleIdList><ArticleId IdType="pubmed">12637088</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo WP, Lin XD, Chen YP, et al. Fourteen types of co-circulating recombinant enterovirus were associated with hand, foot, and mouth disease in children from Wenzhou, China. J Clin Virol. 2015;70:29–38.</Citation><ArticleIdList><ArticleId IdType="pubmed">26305816</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo ZY, Wang ZJ, Meng SL, et al. Analysis of mutation and recombination for coxsackievirus A2 isolated in patients with hand, foot and mouth disease in 2017 in Xiangyang city. Prog Microbiol Immunol. 2019;4:19–21.</Citation></Reference><Reference><Citation>Domingo E, Sabo D, Taniguchi T, et al. Nucleotide sequence heterogeneity of an RNA phage population. Cell. 1978;13(4):735–744.</Citation><ArticleIdList><ArticleId IdType="pubmed">657273</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo E, Holland JJ. RNA virus mutations and fitness for survival. Annu Rev Microbiol. 1997;51:151–178.</Citation><ArticleIdList><ArticleId IdType="pubmed">9343347</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang SG, Shen S, Tay FPL, et al. Selection of and recombination between minor variants lead to the adaptation of an avian coronavirus to primate cells. Biochem Biophys Res Commun. 2005;336(2):417–423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092901</ArticleId><ArticleId IdType="pubmed">16137658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Cui S, Zhao Z, et al. Etiology, pathogenesis, antivirals and vaccines of hand, foot, and mouth disease. Natl Sci Rev. 2015;2:268–284.</Citation></Reference><Reference><Citation>Woodman A, Arnold JJ, Cameron CE, et al. Biochemical and genetic analysis of the role of the viral polymerase in enterovirus recombination. Nucleic Acids Res. 2016;44(14):6883–6895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001610</ArticleId><ArticleId IdType="pubmed">27317698</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold JJ, Cameron CE. Poliovirus RNA-dependent RNA polymerase (3Dpol) is sufficient for template switching in vitro. J Biol Chem. 1999;274(5):2706–2716.</Citation><ArticleIdList><ArticleId IdType="pubmed">9915801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkegaard K, Baltimore D. The mechanism of RNA recombination in poliovirus. Cell. 1986;47(3):433–443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7133339</ArticleId><ArticleId IdType="pubmed">3021340</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowry K, Woodman A, Cook J, et al. Recombination in enteroviruses is a biphasic replicative process involving the generation of greater-than genome length “imprecise” intermediates. PLoS Pathog. 2014;10(6):e1004191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4055744</ArticleId><ArticleId IdType="pubmed">24945141</ArticleId></ArticleIdList></Reference><Reference><Citation>Gmyl AP, Belousov EV, Maslova SV, et al. Nonreplicative RNA recombination in poliovirus. J Virol. 1999;73(11):8958–8965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112927</ArticleId><ArticleId IdType="pubmed">10516001</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao YH, Rouzine IM, Bianco S, et al. RNA recombination enhances adaptability and is required for virus spread and virulence. Cell Host Microbe. 2017;22(3):420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5807061</ArticleId><ArticleId IdType="pubmed">28910639</ArticleId></ArticleIdList></Reference><Reference><Citation>Felsenstein J. The evolutionary advantage of recombination. Genetics. 1974;78(2):737–756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1213231</ArticleId><ArticleId IdType="pubmed">4448362</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller HJ. The relation of recombination to mutational advance. Mutat Res. 1964;106:2–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14195748</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip CCY, Lau SKP, Woo PCY, et al. Recombinant coxsackievirus A2 and deaths of children, Hong Kong, 2012. Emerg Infect Dis. 2013;19(8):1285–1288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3739500</ArticleId><ArticleId IdType="pubmed">23876841</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YF, Du J, Zhao R, et al. Complete genome sequence of a recombinant coxsackievirus B4 from a patient with a fatal case of hand, foot, and mouth disease in Guangxi, China. J Virol. 2012;86(19):10901–10902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3457331</ArticleId><ArticleId IdType="pubmed">22966193</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YJ, Zhang FF, Fu C, et al. Combination of intratypic and intertypic recombinant events in EV71: a novel evidence for the "triple-recombinant" strains of genotype A viruses in mainland China from 2008 to 2010. Virus Genes. 2015;50(3):365–374.</Citation><ArticleIdList><ArticleId IdType="pubmed">25724176</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang WZ, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J. 2010;7:94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LM, Gong YN, Hsieh TH, et al. Discovery of enterovirus A71-like nonstructural genomes in recent circulating viruses of the enterovirus A species. Emerg Microbes Infect. 2018;7(1):111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6013424</ArticleId><ArticleId IdType="pubmed">29930332</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, Utama A, Yoshii K, et al. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997–1998. Jpn J Infect Dis. 1999;52(1):12–15.</Citation><ArticleIdList><ArticleId IdType="pubmed">10808253</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng XB, Guan WC, Guo YF, et al. A novel recombinant lineage’s contribution to the outbreak of coxsackievirus A6-associated hand, foot and mouth disease in Shanghai, China, 2012–2013. Sci Rep. 2015;5:11700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4485158</ArticleId><ArticleId IdType="pubmed">26121916</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin WP, Lu J, Zhang XY, et al. Efficacy of coxsackievirus a5 vaccine candidates in an actively immunized mouse model. J Virol. 2021;95(6):e01743–e1820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8094937</ArticleId><ArticleId IdType="pubmed">33408178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>